Recbio and Rhegen Signed an mRNA Vaccine Cooperation Agreement
TAIZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (referred to as "Recbio") and Shenzhen Rhegen Biotechnology Co., Ltd. (referred to as "Rhegen Bio") recently signed a joint venture agreement to establish a joint venture company "Wuhan Rhecogen Biotechnology Co., Ltd.", to integrate the advantages of both parties and focus on deep and extensive cooperation...
Everest Medicines Initiates Submission of New Drug Application in Hong Kong for XeravaTM for the Treatment of Complicated Intra-abdominal Infections
SHANGHAI, Sept. 29, 2021 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asia, announced today the submission of a New Drug Application (NDA) to the Department of Health, the Hong Kong Special Administrative Region, China, for Xerava™...
Announcing OPEN Health’s New Communications CEO, Margot Hannah
LONDON, Sept. 29, 2021 /PRNewswire/ -- OPEN Health is pleased to announce the appointment of Margot Hannah as the new Chief Executive Officer of OPEN Health Communications. Since joining OPEN Health in 2011, Margot has provided tremendous leadership and dedication to the company. She has held numerous positions, most recently as President of...
Molecular Stethoscope, Inc. Announces Presentation at 16th Annual Sequencing to Function: Analysis and Applications for the Future Meeting
Presentation highlights a path forward to lead the development of the Company's clinical-grade Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform PALO ALTO, Calif., Sept. 29, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a Precision Medicine biotechnology company, announces a presentation at the 2021 16th annual Sequencing to Function: Analysis and Applications for the...
MiZ Company Limited Publishes Review Article on Discovery of Diatomic Molecule That Overcomes Diseases Caused by Chronic Inflammation, Incurable by Modern Medicine
KAMAKURA, Japan, Sept. 29, 2021 /PRNewswire/ -- - Parkinson's Disease, Viral Pneumonia, Pancreatic Cancer, Chronic Kidney Disease, Artificial Dialysis - A paper titled "The overlooked benefits of hydrogen-producing bacteria. -Super beneficial Bacteria-," submitted by MiZ Company Limited (MiZ Co., Ltd.) and co-authored by the University of California, Berkeley, and Keio University, was accepted in Medical Gas Research (STM...
Zhaoke Ophthalmology’s IND Application for Potential First Myopia Drug to Market in China and Globally, NVK-002, Approved for Phase III Clinical Trial by the CDE
Targets broadest patient group – three to 17 years old Two concurrent clinical trials, one leveraging global study to accelerate time to market Phase III clinical trials testing two different doses to tailor for individual patients HONG KONG, Sept. 29, 2021 /PRNewswire/ -- Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or "the Company", SEHK: 6622), a leading ophthalmic...
ClearMask introduces world’s first CE-marked, fully transparent surgical mask
Fully transparent, anti-fog masks available in the European Union to provide clear communication and safety for healthcare providers and essential workers BALTIMORE, Sept. 29, 2021 /PRNewswire/ -- ClearMask LLC, a privately held American medical supply company, announced today that its ClearMask™ is the world's first and only fully transparent surgical mask that is both CE-marked and FDA-cleared. To date,...
Lifebit raises $60m to make vital biomedical data securely accessible for life changing research worldwide
LONDON, Sept. 29, 2021 /PRNewswire/ -- Lifebit Biotech Ltd – the leading precision medicine software company democratising access to biomedical data for governments, healthcare providers and research teams worldwide – has raised a $60 million Series B funding round, led by global investment firm Tiger Global Management. Existing investors Eurazeo, Pentech Ventures, and Beacon Capital also participated. ...
Innovent Releases Preliminary Results of the Phase Ia Dose-Escalation study of IBI315 (Anti-Her2/PD-1 Bispecific Antibody) in Patients with Advanced Solid Tumors at CSCO Annual Meeting 2021
SAN FRANCISCO and SUZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, released the preliminary results of the Phase Ia study of IBI315 (first-in-class anti-Her2/PD-1 bispecific antibody) in an oral presentation at the...
MetaCell launches innovative Cloud Hosting for life science and healthcare
CAMBRIDGE, Mass., Sept. 29, 2021 /PRNewswire/ -- MetaCell, an innovative life science software company specialized in creating cutting-edge research software for major pharma, biotech, and academic institutions, has launched – a brand new online product providing advanced cloud computing solutions to facilitate research and innovation in life science and healthcare organizations of all sizes. MetaCell Cloud...
